'Antibody-conjugated nanoparticles' in Patent Application Approval Process (USPTO 20230405146)

MLA

“‘Antibody-Conjugated Nanoparticles’ in Patent Application Approval Process (USPTO 20230405146).” Biotech Business Week, 8 Jan. 2024, p. 99. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.778496534&authtype=sso&custid=ns315887.

APA

“Antibody-conjugated nanoparticles” in Patent Application Approval Process (USPTO 20230405146). (2024, January 8). Biotech Business Week, 99.

Chicago

Biotech Business Week. 2024. “‘Antibody-Conjugated Nanoparticles’ in Patent Application Approval Process (USPTO 20230405146),” January 8. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.778496534&authtype=sso&custid=ns315887.